Skip to content
Stop using now Drug recall · FDA · Published January 2, 2018

Aurobindo Ampicillin/Sulbactam Injections Recall: Visible Glass Particulates

Aurobindo Pharma recalls 1.5g Ampicillin and Sulbactam injections due to glass particles found in vials. Affected units have NDC 55150-116-20 and lot AF0117001-A. Stop using immediately if you have these products.

🇺🇸 FDA recall #D-0339-2018DrugAurobind: Aurobindo Pharma Ltd. ›
Take action

Contact the company

Recalling firmAurobindo Pharma Ltd.Unit Xii, Lactam Formulation Plant, Survey No. 314, Bachupally, Quthbullapur · Hyderabad, India
✎ GovInfoNow plain-language explainer

Aurobindo Pharma is recalling Ampicillin and Sulbactam injections that contain visible glass particles. This could cause serious injury if injected, so affected users should stop using the product immediately. Read more at govinfonow.com/recall/40958-aurobindo-ampicillin-sulbactam-injections-recall-visible-glass-particulates.

Source Summary by GovInfoNow · govinfonow.com/recall/40958-aurobindo-ampicillin-sulbactam-injections-recall-visible-glass-particulates · Updated October 7, 2026 · FDA enforcement record: FDA #D-0339-2018

Cite this page

“Aurobindo Ampicillin/Sulbactam Injections Recall: Visible Glass Particulates.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40958-aurobindo-ampicillin-sulbactam-injections-recall-visible-glass-particulates. Based on FDA recall #D-0339-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0339-2018%22&limit=1).

The FDA announced on Jan. 2, 2018, that Aurobindo Pharma Ltd. voluntarily recalled Ampicillin and Sulbactam for Injection due to the presence of glass particulate matter in a single vial. The recall affects 53,040 vials distributed nationwide.

How to tell if you have it

  • Brand: Aurobindo Pharma Ltd.
  • Product: Ampicillin and Sulbactam for Injection 1.5 g vial
  • NDC: 55150-116-20
  • Lot Number: AF0117001-A

The hazard

A confirmed customer report identified visible particulate matter, confirmed as glass, within a single vial of the sterile Dry Powder for injection. The recall is classified as Class I.

Context

GovInfoNow's records show Aurobindo Pharma Ltd. has two other recalls on record since March 9, 2012, including a Feb. 2, 2018, recall of Metformin 1000mg for foreign tablet hazards and a March 9, 2012, recall of Northstar Zolpidem for adulterated foreign tablets. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026), Imprimis Dexamethasone Moxifloxacin Eye Drops (Dec. 18, 2025), and American Regent Papaverine HCl Injection (July 24, 2026).

How to tell if you have this one

Check for vials labeled 'Ampicillin and Sulbactam for Injection 1.5 g' with NDC 55150-116-20 and lot number AF0117001-A. The product comes in 10 vials per carton.

  • Brand
    Aurobind: Aurobindo Pharma Ltd.
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discard the vials if you have the recalled product with NDC 55150-116-20 and lot AF0117001-A.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “distributed nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Jan 2, 201812. FDA classified it Class I: Feb 8, 201823. Published in FDA’s Enforcement Report: Feb 14, 201834. FDA terminated the recall: Sep 10, 2019420182019
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0339-2018 (January 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0339-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA